Pharma is one of the few sectors where market entry sequencing is inverted: regulatory approval has to come before commercial strategy, not alongside it. A distribution plan, a pricing model, a hospital partnership pipeline none of it can move ahead of CDSCO/DCGI product registration, because nothing is sellable until that clears. This guide lays out...